Oryzon Genomics Sa operates within the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Oryzon Genomics Sa with three other
miscellaneous service companies in Europe:
sales of 40,798.00 Polish New Zlotys [US$10,716.41 ]
Immunovia AB (publ)
(148,963.00 Swedish Kronor [US$16,013.52 ]
Silence Therapeutics Plc
based in the United Kingdom
(£16,000.00 [US$20,779.20 ]
Sales fell dramatically in 2017:
During the year ended December of 2017, sales at
Oryzon Genomics Sa were 16,764.00 Euro (US$18.86 thousand).
decrease of 97.7%
versus 2016, when the company's sales were 735,312.00 Euro.